Decera Clinical Education Oncology Podcast

Education Podcasts

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Episodes

PARP Inhibitors in Metastatic Prostate Cancer: Biomarker Testing, Treatment Strategies, and Toxicity Management

Experts Discuss Sequencing of Therapies for Relapsed/Refractory Multiple Myeloma

ASCO 2026 Updates in Metastatic Breast Cancer

Evolving Role of B7-H3–Directed ADCs in the Extensive-Stage Small-Cell Lung Cancer Treatment Landscape

Targeting CDH6 in Platinum-Resistant Ovarian Cancer: Emerging ADCs, Biomarkers, and Sequencing

ASCO 2026 Updates in Early Hormone Receptor–Positive Breast Cancer

CELMoDs on the Horizon: A New Chapter in Lymphoma Care

Experts Discuss Health Disparities and Equitable Care Strategies in Multiple Myeloma

Experts Discuss CELMoD Agents for Multiple Myeloma

Optimizing Oral Targeted Therapies for HR+/HER2- Breast Cancer

TGCT Today: Understanding Diagnosis, Treatment, and Long-term Care

Optimizing Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Pharmacist Perspectives

New and Emerging Targeted Therapies for Patients With DLBCL

Changing the Paradigm in HER2-Positive Early Breast Cancer

Recent Advances, Future Directions, and Ideas on Integrating CELMoDs Into The Care Of Patients With Myeloma

To Treat or Not to Treat: Assessing Risk and Treatment Options in High-Risk SMM

Unmet Needs, Recent Advances, and Expert Insights on Integrating TROP-2 ADCs Into the Care of Patients With TNBC

Optimizing Bispecific Antibody Safety and Care Coordination From the Pharmacy in RRMM

Targeting the Future of Pancreatic Cancer Care: RAS, Biomarkers, and Emerging Therapies

Beyond BCMA: How GPRC5D-Targeted Therapy Fits Iinto Multiple Myeloma Care Today